title: Hepatitis C virus seroprevalence in the Netherlands.
abstract: A population-based anti-hepatitis C virus (HCV) prevalence is important for surveillance purposes and it provides an insight into the burden of disease. In The Netherlands, a recent HCV seroprevalence estimate is not available. This national population-based cross-sectional serosurvey (PIENTER-2) resulted in a weighted national HCV seroprevalence of 0.30% (95% confidence interval 0.05-0.55%). About 70% of the HCV positive individuals found were born in an HCV-endemic country.
authors.affiliation: National Institute for Public Health and the Environment, Center for Infectious Disease Control, Bilthoven, The Netherlands. rianne.vriend@rivm.nl
authors.forename: Henrike J
authors.initials: HJ
authors.lastname: Vriend
authors.forename: Eline L M
authors.initials: EL
authors.lastname: Op de Coul
authors.forename: Thijs J W
authors.initials: TJ
authors.lastname: van de Laar
authors.forename: Anouk T
authors.initials: AT
authors.lastname: Urbanus
authors.forename: Fiona R M
authors.initials: FR
authors.lastname: van der Klis
authors.forename: Hein J
authors.initials: HJ
authors.lastname: Boot
mesh_terms: D000293:Adolescent; D000328:Adult; D000368:Aged; D003430:Cross-Sectional Studies; D005260:Female; D005838:Genotype; D016174:Hepacivirus / Q000235:genetics / Q000276:immunology*; D006526:Hepatitis C / Q000097:blood / Q000175:diagnosis / Q000453:epidemiology*; D018937:Hepatitis C Antibodies / Q000097:blood; D006801:Humans; D007124:Immunoenzyme Techniques; D007155:Immunologic Factors; D008297:Male; D008875:Middle Aged; D009426:Netherlands / Q000453:epidemiology; D011159:Population Surveillance; D015995:Prevalence; D012367:RNA, Viral / Q000032:analysis; D012307:Risk Factors; D016036:Seroepidemiologic Studies; D012959:Socioeconomic Factors; D011795:Surveys and Questionnaires; D055815:Young Adult
chemical_list: D018937:Hepatitis C Antibodies; D007155:Immunologic Factors; D012367:RNA, Viral